178 related articles for article (PubMed ID: 28874771)
1. Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract.
Guo SH; Wang HF; Nian ZG; Wang YD; Zeng QY; Zhang G
Sci Rep; 2017 Sep; 7(1):10566. PubMed ID: 28874771
[TBL] [Abstract][Full Text] [Related]
2. Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine.
O'Riordan AA; Morales VA; Mulligan L; Faheem N; Windle HJ; Kelleher DP
Vaccine; 2012 Jun; 30(26):3876-84. PubMed ID: 22512976
[TBL] [Abstract][Full Text] [Related]
3.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.
Chen T; Li Q; Wu J; Wu Y; Peng W; Li H; Wang J; Tang X; Peng Y; Fu X
Cancer Immunol Immunother; 2018 Oct; 67(10):1635-1646. PubMed ID: 30121899
[TBL] [Abstract][Full Text] [Related]
5.
Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
Front Immunol; 2021; 12():658681. PubMed ID: 34093546
[No Abstract] [Full Text] [Related]
6. Fn-Dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer.
Wu Y; Guo S; Chen F; Li Y; Huang Y; Liu W; Zhang G
PLoS Pathog; 2023 Jan; 19(1):e1011096. PubMed ID: 36693067
[TBL] [Abstract][Full Text] [Related]
7. Alkyl hydroperoxide reductase is required for Helicobacter cinaedi intestinal colonization and survival under oxidative stress in BALB/c and BALB/c interleukin-10-/- mice.
Charoenlap N; Shen Z; McBee ME; Muthupalani S; Wogan GN; Fox JG; Schauer DB
Infect Immun; 2012 Mar; 80(3):921-8. PubMed ID: 22184416
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of Intestinal
Peng BJ; Cao CY; Li W; Zhou YJ; Zhang Y; Nie YQ; Cao YW; Li YY
Chin Med J (Engl); 2018 Jun; 131(11):1349-1356. PubMed ID: 29786050
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.
Wang HF; Li LF; Guo SH; Zeng QY; Ning F; Liu WL; Zhang G
Sci Rep; 2016 Sep; 6():33440. PubMed ID: 27678333
[TBL] [Abstract][Full Text] [Related]
11. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade.
Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X
Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma.
Park HE; Kim JH; Cho NY; Lee HS; Kang GH
Virchows Arch; 2017 Sep; 471(3):329-336. PubMed ID: 28597080
[TBL] [Abstract][Full Text] [Related]
13. Production of polyclonal antibody against alkyl hydroperoxide reductase of Helicobacter pylori and its antigenicity.
Mohammadian T; Doosti M; Paknejad M; Siavoshi F; Massarrat S; Soukhtanloo M
Hybridoma (Larchmt); 2008 Dec; 27(6):481-5. PubMed ID: 19108621
[TBL] [Abstract][Full Text] [Related]
14.
Yang Z; Ji G
Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
[TBL] [Abstract][Full Text] [Related]
15. Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess.
Klug TE
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260599
[TBL] [Abstract][Full Text] [Related]
16. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium and Enterobacteriaceae: important players for CRC?
Allen-Vercoe E; Jobin C
Immunol Lett; 2014 Dec; 162(2 Pt A):54-61. PubMed ID: 24972311
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model.
Gemmell E; Bird PS; Ford PJ; Ashman RB; Gosling P; Hu Y; Seymour GJ
Oral Microbiol Immunol; 2004 Aug; 19(4):247-51. PubMed ID: 15209995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]